Telomir Pharmaceuticals (TELO) News Today

→ Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad)

Free TELO Stock Alerts

$5.55

-0.08 (-1.42%)

(As of 10:50 AM ET)

Stock Analysis Chart Competitors Earnings Financials Headlines Ownership SEC Filings Trends

Source

May 30, 2024 | globenewswire.com

Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1

May 14, 2024 | investorplace.com

TELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q1 2024

April 22, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 11:04 AM with a stated reason of "LULD pause."

April 16, 2024 | globenewswire.com

Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.

April 2, 2024 | globenewswire.com

Telomir Pharmaceuticals' Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024

March 29, 2024 | globenewswire.com

UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

March 26, 2024 | globenewswire.com

Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

March 22, 2024 | globenewswire.com

Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th

March 14, 2024 | globenewswire.com

Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate's Potential in DNA Age Reversal Science

March 7, 2024 | globenewswire.com

Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conference

March 7, 2024 | globenewswire.com

Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conference

March 5, 2024 | globenewswire.com

Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal

February 20, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 10:02 AM with a stated reason of "LULD pause."

February 14, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 03:02 PM with a stated reason of "LULD pause."

February 14, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 03:02 PM with a stated reason of "LULD pause."

February 14, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 02:02 PM with a stated reason of "LULD pause."

February 14, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 02:02 PM with a stated reason of "LULD pause."

February 14, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 01:02 PM with a stated reason of "LULD pause."

February 12, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 01:02 PM with a stated reason of "LULD pause." Trading set to resume at 01:02 PM.

February 9, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 11:02 AM with a stated reason of "LULD pause."

February 9, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 11:02 AM with a stated reason of "LULD pause."

February 9, 2024 | marketbeat.com

Trading was temporarily halted for "TELO" at 10:02 AM with a stated reason of "LULD pause."

Get Telomir Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter.

Executive Order To Wipe Out Your Bank Accounts (Ad)

Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.

Click Here To Get Your FREE Guide Now!

TELO Media Mentions By Week

TELO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TELO
News Sentiment
▼
0.00

0.76
▲
Average
Medical
News Sentiment

TELO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TELO Articles
This Week
▼
0

1
▲
TELO Articles
Average Week

Get Telomir Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter.

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:TELO) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners

Web Analytics

Get 30 Days of MarketBeat All Access Free

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial